Svf Investments (uk) Ltd - Net Worth and Insider Trading
Svf Investments (uk) Ltd Net Worth
The estimated net worth of Svf Investments (uk) Ltd is at least $8.5 Billion dollars as of 2024-05-10. Svf Investments (uk) Ltd is the 10% Owner of Coupang Inc and owns about 349,542,259 shares of Coupang Inc (CPNG) stock worth over $7.7 Billion. Svf Investments (uk) Ltd is the 10% Owner of Roivant Sciences Ltd and owns about 73,031,667 shares of Roivant Sciences Ltd (ROIV) stock worth over $823 Million. Svf Investments (uk) Ltd is also the 10% Owner of Sio Gene Therapies Inc and owns about 13,244,048 shares of Sio Gene Therapies Inc (SIOX) stock worth over $6 Million. Details can be seen in Svf Investments (uk) Ltd's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Svf Investments (uk) Ltd has not made any transactions after 2024-03-13 and currently still holds the listed stock(s).
Transaction Summary of Svf Investments (uk) Ltd
Svf Investments (uk) Ltd Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Svf Investments (uk) Ltd owns 6 companies in total, including Arbutus Biopharma Corp (ABUS) , Sio Gene Therapies Inc (SIOX) , and Myovant Sciences Ltd (MYOV) among others .
Click here to see the complete history of Svf Investments (uk) Ltd’s form 4 insider trades.
Insider Ownership Summary of Svf Investments (uk) Ltd
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ABUS | Arbutus Biopharma Corp | 2017-09-06 | 10 percent owner |
| SIOX | Sio Gene Therapies Inc | 2019-03-18 | 10 percent owner |
| MYOV | Myovant Sciences Ltd | 2017-09-06 | 10 percent owner |
 | | 2019-07-10 | other: Former 10% Owner |
| | 2023-09-28 | 10 percent owner |
| | 2024-03-13 | 10 percent owner |
Svf Investments (uk) Ltd Latest Holdings Summary
Svf Investments (uk) Ltd currently owns a total of 3 stocks. Among these stocks, Svf Investments (uk) Ltd owns 349,542,259 shares of Coupang Inc (CPNG) as of March 13, 2024, with a value of $7.7 Billion and a weighting of 90.27%. Svf Investments (uk) Ltd owns 73,031,667 shares of Roivant Sciences Ltd (ROIV) as of September 28, 2023, with a value of $823 Million and a weighting of 9.66%. Svf Investments (uk) Ltd also owns 13,244,048 shares of Sio Gene Therapies Inc (SIOX) as of March 18, 2019, with a value of $6 Million and a weighting of 0.07%.
Latest Holdings of Svf Investments (uk) Ltd
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CPNG | Coupang Inc | 2024-03-13 | 349,542,259 | 22.01 | 7,693,425,121 |
| ROIV | Roivant Sciences Ltd | 2023-09-28 | 73,031,667 | 11.27 | 823,066,887 |
| SIOX | Sio Gene Therapies Inc | 2019-03-18 | 13,244,048 | 0.48 | 6,330,655 |
Holding Weightings of Svf Investments (uk) Ltd
Svf Investments (uk) Ltd Form 4 Trading Tracker
According to the SEC Form 4 filings, Svf Investments (uk) Ltd has made a total of 5 transactions in Coupang Inc (CPNG) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Coupang Inc is the sale of 46,614,154 shares on March 13, 2024, which brought Svf Investments (uk) Ltd around $895 Million.
According to the SEC Form 4 filings, Svf Investments (uk) Ltd has made a total of 1 transactions in Roivant Sciences Ltd (ROIV) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Roivant Sciences Ltd is the sale of 10,000,000 shares on September 28, 2023, which brought Svf Investments (uk) Ltd around $126 Million.
According to the SEC Form 4 filings, Svf Investments (uk) Ltd has made a total of 0 transactions in Sio Gene Therapies Inc (SIOX) over the past 5 years. The most-recent trade in Sio Gene Therapies Inc is the acquisition of 833,333 shares on March 18, 2019, which cost Svf Investments (uk) Ltd around $10 Million.
Insider Trading History of Svf Investments (uk) Ltd
- 1
Svf Investments (uk) Ltd Trading Performance
GuruFocus tracks the stock performance after each of Svf Investments (uk) Ltd's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Svf Investments (uk) Ltd is 7.19%. GuruFocus also compares Svf Investments (uk) Ltd's trading performance to market benchmark return within the same time period. The performance of stocks bought by Svf Investments (uk) Ltd within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Svf Investments (uk) Ltd's insider trading performs compared to the benchmark.
Performance of Svf Investments (uk) Ltd
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 7.28 | | | | | |
| Relative Return to S&P 500(%) | 4.95 | | | | | |
Svf Investments (uk) Ltd Ownership Network
Svf Investments (uk) Ltd Owned Company Details
What does Arbutus Biopharma Corp do?
Who are the key executives at Arbutus Biopharma Corp?
Svf Investments (uk) Ltd is the 10 percent owner of Arbutus Biopharma Corp. Other key executives at Arbutus Biopharma Corp include Chief Financial Officer David C Hastings , Chief Business Officer Michael J. Mcelhaugh , and Chief Scientific Officer Michael J. Sofia .
Arbutus Biopharma Corp (ABUS) Insider Trades Summary
Over the past 18 months, Svf Investments (uk) Ltd made no insider transaction in Arbutus Biopharma Corp (ABUS). Other recent insider transactions involving Arbutus Biopharma Corp (ABUS) include a net sale of 10,164 shares made by Michael J. Mcelhaugh , a net sale of 9,982 shares made by Michael J. Sofia , and a net sale of 9,593 shares made by David C Hastings .
In summary, during the past 3 months, insiders sold 0 shares of Arbutus Biopharma Corp (ABUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 34,097 shares of Arbutus Biopharma Corp (ABUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 34,097 shares.
Arbutus Biopharma Corp (ABUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arbutus Biopharma Corp Insider Transactions
Svf Investments (uk) Ltd Mailing Address
Above is the net worth, insider trading, and ownership report for Svf Investments (uk) Ltd. You might contact Svf Investments (uk) Ltd via mailing address: 69 Grosvenor Street, London X0 W1k3jp.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
